We then went on to identify four genes from our IPA BioProfiler analysis that had current targeted therapies approved for use in other cancers: CDK6, COL25A1, MMP16, PRIM2, which highlights the potential sex-specific utility of these genes and their encoded proteins as therapeutic targets for future study. Here, MMP16 is linked to cancer.